GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » Cash Flow for Lease Financing

Viva Biotech Holdings (FRA:VB0) Cash Flow for Lease Financing : €-0.6 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Cash Flow for Lease Financing?

Viva Biotech Holdings's Cash Flow for Lease Financing for the six months ended in Dec. 2024 was €-0.2 Mil. Viva Biotech Holdings's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.6 Mil.

Compared with last quarter (€-0.3 Mil in Jun. 2024 ), Viva Biotech Holdings's Cash Flow for Lease Financing increased in Dec. 2024 (€-0.2 Mil).

Viva Biotech Holdings Cash Flow for Lease Financing Historical Data

The historical data trend for Viva Biotech Holdings's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Cash Flow for Lease Financing Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only -1.94 -1.96 -0.64 -0.54 -0.56

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 -0.19 -0.35 -0.34 -0.22

Viva Biotech Holdings Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viva Biotech Holdings Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » Cash Flow for Lease Financing
Comparable Companies
HKSE:01167 HKSE:02179 HKSE:01541 HKSE:02480 HKSE:02487 HKSE:02509 HKSE:06660 HKSE:01521 HKSE:02616 HKSE:06996 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
VBIZF:USA 01873:Hong Kong VB0:Germany
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Website
https://www.vivabiotech.com
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.

Viva Biotech Holdings Headlines

No Headlines